financetom
Business
financetom
/
Business
/
Robinhood Ventures Fund II (RVII) Announces Pricing of Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Robinhood Ventures Fund II (RVII) Announces Pricing of Initial Public Offering
Aug 12, 2026 11:09 PM

Image: Robinhood Ventures Fund II

MENLO PARK, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Ventures Fund II (RVII) announced the pricing of its initial public offering of 8,000,000 common shares of beneficial interest at an initial public offering price of $25.00 per share. This brings the total size of the Fund to $225.5 million, or up to $255.5 million if the underwriter’s option to purchase additional common shares is exercised in full. The total fund size is calculated before deducting the sales load and offering expenses.

The shares are expected to begin trading on the New York Stock Exchange (NYSE) on Aug. 13, 2026 under the symbol RVII, and the offering is expected to close on Aug. 14, 2026, subject to the satisfaction of customary closing conditions.

RVII has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 common shares of beneficial interest from RVII at the same price as the initial offering price, less underwriting discounts and commissions.

RVII is a business development company (“BDC”), a type of closed-end fund, that provides retail investors exposure to a diversified portfolio of private companies in their earliest stages. Investors can learn more by reading the registration statement.

Goldman Sachs & Co. LLC is the lead bookrunner for the offering. Citigroup, J.P. Morgan, UBS Investment Bank, and Wells Fargo Securities are joint bookrunners for the offering.

A registration statement relating to the sale of common shares of beneficial interest of RVII was declared effective by the Securities and Exchange Commission on Aug. 12, 2026.

This offering is being made only by means of a final prospectus. Copies of the final prospectus related to the offering, when available, may be obtained by contacting Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526 or by emailing [email protected]; J.P. Morgan Securities LLC, Attention: c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or email: [email protected] and [email protected]; Citigroup, ℅ Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel:800-831-9146); Wells Fargo Securities LLC, 608 2nd Avenue South, Minneapolis, MN 55402, at 800-645-3751 (option #5) or email a request to [email protected]; or UBS Securities LLC, Attention: Equity Syndicate, 11 Madison Avenue, New York, NY 10010, by telephone at (888) 827-7275, or by email at [email protected]. Investors are advised to carefully consider the investment objectives, risks and charges and expenses of RVII before investing. The prospectus, which contains this and other information about RVII, should be read carefully before investing.

This press release is being made pursuant to, and in accordance with, Rule 134 under the Securities Act of 1933, as amended, and shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Disclosures:

An investment in Robinhood Ventures Fund II is speculative and involves a high degree of risk with substantial risk of loss.

Robinhood Ventures is the investment adviser for RVII. Robinhood Ventures is the dba name for Robinhood Ventures DE, LLC. Robinhood Ventures is an SEC-registered investment adviser and a wholly owned subsidiary of Robinhood Markets, Inc. ( HOOD )

Forward-Looking Statements

This communication includes “forward looking statements,” including with respect to the completion of RVII’s initial public offering and the expected listing of RVII’s shares on the New York Stock Exchange under the symbol “RVII.” These statements also include statements regarding RVII’s objectives to provide retail investors exposure to a diversified portfolio of private companies in their earliest stages, to make seed investments in companies across sectors, to focus on companies that are current or previous participants in the Y Combinator startup accelerator program or companies with a founder or co-founder that participated in the program, and other statements that are not historical facts. You can sometimes identify forward-looking statements through the use of words or phrases such as “will,” “expect,” “anticipated,” “aim,” “intended,” or similar words and expressions of the future. Forward-looking statements involve known and unknown risks, uncertainties and assumptions, including the risks outlined under “Risks” in the preliminary prospectus and elsewhere in RVII’s filings with the SEC, which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement. RVII and Robinhood have no obligation, and do not undertake any obligation, to update or revise any forward-looking statement made in this communication to reflect changes since the date of this communication, except as required by law.

5838116

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3996552d-6798-448d-8a01-f28794b80be2

Image: https://www.globenewswire.com/newsroom/ti?nf=OTgwOTM3MCM3Nzc0NTk0IzIyMDYyNDA=

Image: https://ml.globenewswire.com/media/NjYxZWE0NWYtZDU3Ny00ZTI1LTk2NDItZjY2YTk3YjFiZjJhLTEyMTc3OTMtMjAyNi0wOC0xMy1lbg==/tiny/Robinhood-Markets-Inc-.png Image: Primary Logo

Robinhood Ventures Fund II

Image: https://ml.globenewswire.com/media/3996552d-6798-448d-8a01-f28794b80be2/medium/robinhood-ventures-fund-ii.png

Introducing Robinhood Ventures Fund II (RVII)

Source: Robinhood Markets, Inc. ( HOOD )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. FDA approves ImmunityBio's bladder cancer therapy
U.S. FDA approves ImmunityBio's bladder cancer therapy
Apr 22, 2024
April 22 (Reuters) - The U.S. FDA approved ImmunityBio's ( IBRX ) combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market. ...
Copper output at Chile's Codelco set to rise this year, CESCO says
Copper output at Chile's Codelco set to rise this year, CESCO says
Apr 22, 2024
SANTIAGO (Reuters) - Chile's state-run copper miner Codelco is poised to improve production this year and begin to climb from its lowest dip in a quarter century, the head of Chilean copper studies center CESCO said ahead of a major industry conference that starts Monday. Codelco is aiming to produce between 1.325 million and 1.390 million metric tons of copper...
ADM CFO to resign as company faces US government investigation
ADM CFO to resign as company faces US government investigation
Apr 22, 2024
(Reuters) - Grain trader Archer-Daniels-Midland ( ADM ) said on Monday that Chief Financial Officer Vikram Luthar will resign from his role effective Sept. 30. Luthar is the highest-level executive to leave the firm since it disclosed accounting issues within its Nutrition division that later triggered two government investigations and forced it to revise six years of financial data. ADM...
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Apr 22, 2024
06:00 PM EDT, 04/22/2024 (MT Newswires) -- Clearwater Analytics ( CWAN ) said Monday it completed the acquisition of risk and performance analytics products from Wilshire Advisors. Wilshire Axiom, Wilshire Atlas, Wilshire Abacus and Wilshire iQComposite will be integrated with Clearwater's offerings. Clearwater previously said the assets will cost $40 million and add about $7 million in annualized revenue. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved